首页/数据集/Fulcrum Therapeutics total assets 2021-2025

Fulcrum Therapeutics total assets 2021-2025

Statista2026-04-11 收录

生物制药分析

罕见病疗法企业评估

数据链接：

https://www.statista.com/statistics/1524441/fulcrum-therapeutics-total-assets/数据链接链接失效反馈

官方服务：

资源简介：

Total assets of Fulcrum Therapeutics from 2021 to 2025 (in million U.S. dollars)

应用场景：

相关数据集

Etanercept glycoform assignment

生物制药分析

糖基化表征

ZIP archive containing raw spectra (in RAW and mzML format); MoFi parameter and output files; processed results and the corresponding processing scripts; glycopeptide data. See the readme file for fur

NIAID Data Ecosystem100

Ocular Therapeutix operating profit 2021-2025

生物制药财务

生物制药分析

Operating profit of Ocular Therapeutix from 2021 to 2025 (in million U.S. dollars)

Statista70

Quantitation of supercoiled circular content in plasmid DNA solutions using a fluorescence-based method

质粒DNA制造

生物制药分析

A method for quantifying the proportion of supercoiled circular (SC) forms in DNA solutions is described. The method (SCFluo) takes advantage of the reversible denaturation property of SC forms and th

PubMed Central2000-06-15 更新30

Savara net income 2020 to 2024

企业财务绩效

生物制药分析

Net income of Savara from 2020 to 2024 (in million U.S. dollars)

Statista100

Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoproteins

聚合物合成

生物制药分析

This is data generated during my Marie Curie project. It includes the results for the synthesis of the monomers and polymerised high internal phase emulsions (polyHIPEs). In addition, supplementary

NIAID Data Ecosystem40